MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Overweight (E66.3)

HealthDay 25 June at 03.01 PM

Intermittent Fasting Aids Early Diabetes Outcomes More Than Drugs

Intermittent fasting may be a more effective intervention than drugs for people with early diabetes and either obesity or overweight, according to a study published online June 21 in JAMA Network Open.Lixin Guo, M.D., from the Chinese Academy of Medical Sciences in Beijing, and colleagues evaluated the effect of intermittent fasti

HealthDay 20 June at 08.50 PM

Timing of Exercise Significant for Obesity, Metabolic Impairment

For sedentary adults with obesity/overweight and metabolic impairments, the timing of moderate-to-vigorous physical activity (MVPA) is significant, with a beneficial effect on glucose homeostasis for accumulation of more MVPA in the evening, according to a study published online June 10 in Obesity.Antonio Clavero-Jimeno, from the Univ

Evalytics 05 March at 06.03 AM

Metformin's Potential Beyond Diabetes: Exploring Diverse Health Benefits

Metformin, a frontline treatment for type 2 diabetes, has long been a pharmaceutical mainstay, with over 91 million prescriptions in 2021 alone. However, recent evidence suggests that metformin's efficacy extends beyond diabetes management, encompassing various conditions such as cancer, obesity, liver disease, cardiovascular issues, neurodegenerative disorders, and renal diseases. As research exp

HealthDay 31 January at 04.57 PM

Cardio, Cardio + Resistance Training Improve CVD Risk Profile at One Year

In adults with overweight or obesity, aerobic exercise alone or a combined resistance plus aerobic exercise program leads to improvements in composite cardiovascular disease (CVD) risk profiles at one year, according to a study published online Jan. 17 in the European Heart Journal.Duck-chul Lee, Ph.D., from Iowa State Universit

HealthDay 30 January at 04.20 PM

Diabetes Risk in Overweight, Obese Teens Varies Substantially by Baseline HbA1c

Five-year diabetes risk among teens with overweight or obesity varies substantially by baseline HbA1c levels, according to a study published online Jan. 17 in JAMA Network Open.Francis M. Hoe, M.D., from Kaiser Permanente Roseville Medical Center in California, and colleagues assessed the risk for future type 2 diabetes (T2D) amon

HealthDay 17 January at 04.52 PM

Individual Variation in Depressive Symptoms Tied to Subsequent Weight Gain

WEDNESDAY, Jan. 17, 2024 (HealthDay News) -- Individuals with overweight or obesity are more vulnerable to short-term weight gain following individual increases in depressive symptoms, according to a study published online Jan. 10 in PLOS ONE.Julia Mueller, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues assessed how small fluctuations in

HealthDay 12 January at 04.32 PM

Rate of Twin Births Increased in Pregnancies With Higher BMI

The rate of twin deliveries increased with increasing body mass index (BMI), and part of this association was explained by higher use of assisted reproductive technology (ART), according to a study published online Jan. 9 in JAMA Network Open.Jeffrey N. Bone, from the University of British Columbia in Vancouver, Canada, and colleag

HealthDay 09 January at 05.09 PM

Risk for Suicidal Ideation Not Increased With Semaglutide

For individuals with overweight or obesity and type 2 diabetes, semaglutide is not associated with an increased risk for suicidal ideation compared with non-glucagon-like peptide 1 receptor (GLP1R) agonist antiobesity medications, according to a study published online Jan. 5 in Nature Medicine.William Wang, from the Case Western Reserve

HealthDay 13 December at 10.08 PM

New Poll Finds Older Americans Believe Medicare Should Cover Weight-Loss Drugs

According to the latest University of Michigan National Poll on Healthy Aging, about three in four older Americans (76 percent) believe Medicare should cover the cost of weight-loss medications like Ozempic, Wegovy, or Zepbound.More than four out of five older adults (83 percent) think insurance companies should pay for drugs that help people

HealthDay 13 December at 03.42 PM

Perfluorooctanesulfonic Acid Exposure Linked to Lower Bone Density

In a cohort of Hispanic adolescents and young adults, plasma perfluorooctanesulfonic acid (PFOS) exposure is associated with lower bone mineral density (BMD), according to a study published online Dec. 6 in Environmental Research.Emily Beglarian, M.P.H., from the Keck School of Medicine at the University of Southern California in Los

HealthDay 13 December at 03.33 PM

Increasing Body Mass Index Tied to 18 Site-Specific Cancers in Men

Increasing body mass index (BMI) at age 18 years is associated with development of subsequent site-specific cancers in men, according to a study published online Nov. 6 in Obesity.Aron Onerup, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues examined BMI at age 18 years and incident site-specific cancer (

HealthDay 12 December at 04.02 PM

Small Proportion of Advanced Breast Cancers Due to Biennial Versus Annual Mammogram

Among routinely screened women, only a small proportion of advanced breast cancers is attributed to biennial versus annual screening, according to a study published online Dec. 7 in JAMA Oncology.Karla Kerlikowske, M.D., from the University of California in San Francisco, and colleagues examined the population attributable risk proport

HealthDay 11 December at 11.55 PM

High BMI in Adolescence Linked to Early CKD in Young Adulthood

High body mass index (BMI) in late adolescence is associated with early chronic kidney disease (CKD) in young adulthood, according to a study published online Dec. 11 in JAMA Pediatrics.Avishai M. Tsur, M.D., from the Israel Defense Forces, Medical Corps, in Ramat Gan, and colleagues examined the association between adolescent BMI and e

HealthDay 11 December at 04.32 PM

Risk for CRC Reduced With GLP-1RAs for Drug-Naive Patients With T2D

For drug-naive patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1RAs) are associated with a reduced risk for colorectal cancer (CRC) compared with other antidiabetics, including insulin and metformin, according to a research letter published online Dec. 7 in JAMA Oncology.Lindsey Wang, from the Case We

HealthDay 07 December at 04.41 PM

Slow-to-Moderate Weight Loss Linked to Lower Mortality in Knee, Hip OA

For individuals with overweight or obesity and knee or hip osteoarthritis (OA), a slow-to-moderate, but not a fast, rate of weight loss is associated with a reduced risk for all-cause mortality, according to a study published online Dec. 6 in Arthritis & Rheumatology.Jie Wei, Ph.D., from Xiangya Hospital in Changsha, China, and col

HealthDay 05 December at 04.19 PM

Lower Pregnancy Weight Gain Seen for Women Who Undergo Bariatric Surgery

Women who have undergone bariatric surgery have lower pregnancy weight gain, according to a study published online Dec. 5 in JAMA Network Open.Huiling Xu, M.D., from the Karolinska Institutet in Stockholm, and colleagues compared pregnancy weight gain among women with a history of bariatric surgery versus those without in a nationwide,

HealthDay 28 November at 04.42 PM

Impacts of Gestational Weight Gain Seen 50+ Years Later

Gestational weight gain might have implications that extend beyond the pregnancy window to long-term health, according to a study published in the Nov. 18 issue of The Lancet.Stefanie N. Hinkle, Ph.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues assessed whether gestationa

HealthDay 09 November at 04.08 PM

FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro

A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active ingredient, tirzepatide, as the diabetes drug Mounjaro.Zepbound works by activating hormone receptors in the body to reduce appetite